Recent events
Recent events tied to this brand in public sources.
Back to profile3 entries
2022
Helix BioPharma announces CFO's planned departure
Helix BioPharma announced that CFO Frank Michalargias intends to resign from his position, effective no later than May 15, 2022, to pursue a new employment opportunity.
2020
Helix BioPharma closes private placement
Helix BioPharma announced that it had closed a private placement financing for gross proceeds of $3,000,000. The company said it intended to use the net proceeds for working capital and research and development activities.
2020
Helix BioPharma closes private placement
Helix BioPharma announced that it closed a private placement financing for gross proceeds of $1,100,000. It said it intended to use the net proceeds for working capital and research and development activities.